BCL2A1 and Langerhans cell histiocytosis: Here, we investigated whether BCL2A1 expression was correlated with Mo-DC survival in LCH patients, by measuring viable cells viaDiOC6+PI– uptake by flow cytometry at day seven (Figures 2D, E).